| Fresenius Kabi (Schweiz) AG - Piperacillin/Tazobactam Fresenius i.v. 4 g/0.5 g, Pulver zur Herstellung einer Infusionslösung |
| 63001 | | 02 | | Piperacillin/Tazobactam Fresenius i.v. 4 g/0.5 g | | Pulver zur Herstellung einer Infusionslösung | | J01CR05 | | Piperacillin and Beta-Lactamase Inhibitor | | 05.12.2013 | | |
|
| Composition |
| Praeparatio cryodesiccata: piperacillinum 4 g ut piperacillinum natricum 4.17 g, tazobactamum 500 mg ut tazobactamum natricum 536.6 mg, pro vitro corresp. natrium 224 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Piperacilline | 4 g | | Tazobactame | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Piperacilline | 4 g | | Tazobactame | 0.5 g |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | Flasche(n) | 19.49 | 37.55 | A | SL | No | | 004 | 10 Flasche(n) | | | A | | No |
|
